异动解读 | 平价减肥药大卖助推Hims & Hers Health Inc.(HIMS)股价盘中大涨15.14%

异动解读

02-19

加州旧金山医疗科技公司Hims & Hers Health Inc.（HIMS）股价今日盘中大涨15.14%,引发市场广泛关注。

导致公司股价大涨的主要原因是,去年5月该公司以较低价格推出诺和诺德公司(Novo Nordisk)知名减肥药物司美格鲁肽的复方版本,迅速引发了消费者热捧。自此以来,HIMS股价已累计上涨逾200%。

虽然司美格鲁肽原药供应持续短缺,但HIMS提供的替代方案的受欢迎程度持续推升了这家远程医疗公司的业绩表现,引发华尔街对其2024年第四季度财报报表持乐观预期。不过,投行摩根士丹利则警告称,HIMS近期涨幅过大,适当时机已错失,给予"持平"评级并大幅下调目标价。该投行预计HIMS今年一季度业绩或将逊于市场预期。

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1167671615"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1167671615\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1167671615?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-02-19 23:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167671615","market":"us","top_or_hot":-1,"title":"异动解读 | 平价减肥药大卖 助推Hims & Hers Health Inc.(HIMS)股价盘中大涨15.14%","media":"异动解读","content":"<p>加州旧金山医疗科技公司Hims & Hers Health Inc.（HIMS）股价今日盘中大涨15.14%,引发市场广泛关注。</p>\n\n<p>导致公司股价大涨的主要原因是,去年5月该公司以较低价格推出诺和诺德公司(Novo Nordisk)知名减肥药物司美格鲁肽的复方版本,迅速引发了消费者热捧。自此以来,HIMS股价已累计上涨逾200%。</p>\n\n<p>虽然司美格鲁肽原药供应持续短缺,但HIMS提供的替代方案的受欢迎程度持续推升了这家远程医疗公司的业绩表现,引发华尔街对其2024年第四季度财报报表持乐观预期。不过,投行摩根士丹利则警告称,HIMS近期涨幅过大,适当时机已错失,给予\"持平\"评级并大幅下调目标价。该投行预计HIMS今年一季度业绩或将逊于市场预期。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 平价减肥药大卖 助推Hims & Hers Health Inc.(HIMS)股价盘中大涨15.14%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 平价减肥药大卖 助推Hims & Hers Health Inc.(HIMS)股价盘中大涨15.14%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092702339\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">异动解读 </p>\n<p class=\"h-time\">2025-02-19 23:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>加州旧金山医疗科技公司Hims & Hers Health Inc.（HIMS）股价今日盘中大涨15.14%,引发市场广泛关注。</p>\n\n<p>导致公司股价大涨的主要原因是,去年5月该公司以较低价格推出诺和诺德公司(Novo Nordisk)知名减肥药物司美格鲁肽的复方版本,迅速引发了消费者热捧。自此以来,HIMS股价已累计上涨逾200%。</p>\n\n<p>虽然司美格鲁肽原药供应持续短缺,但HIMS提供的替代方案的受欢迎程度持续推升了这家远程医疗公司的业绩表现,引发华尔街对其2024年第四季度财报报表持乐观预期。不过,投行摩根士丹利则警告称,HIMS近期涨幅过大,适当时机已错失,给予\"持平\"评级并大幅下调目标价。该投行预计HIMS今年一季度业绩或将逊于市场预期。</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1167671615","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167671615","pubTimestamp":1739977483,"columns":[],"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"加州旧金山医疗科技公司Hims & Hers Health Inc.股价今日盘中大涨15.14%,引发市场广泛关注。自此以来,HIMS股价已累计上涨逾200%。虽然司美格鲁肽原药供应持续短缺,但HIMS提供的替代方案的受欢迎程度持续推升了这家远程医疗公司的业绩表现,引发华尔街对其2024年第四季度财报报表持乐观预期。不过,投行摩根士丹利则警告称,HIMS近期涨幅过大,适当时机已错失,给予\"持平\"评级并大幅下调目标价。该投行预计HIMS今年一季度业绩或将逊于市场预期。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"HIMS & Hers Health Inc. (HIMS) stock surged 15.14% intraday on the sale of affordable weight loss pills","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"加州旧金山医疗科技公司Hims & Hers Health Inc.（HIMS）股价今日盘中大涨15.14%,引发市场广泛关注。\n导致公司股价大涨的主要原因是,去年5月该公司以较低价格推出诺和诺德公司(Novo Nordisk)知名减肥药物司美格鲁肽的复方版本,迅速引发了消费者热捧。自此以来,HIMS股价已累计上涨逾200%。\n虽然司美格鲁肽原药供应持续短缺,但HIMS提供的替代方案的受欢迎程度持续推升了这家远程医疗公司的业绩表现,引发华尔街对其2024年第四季度财报报表持乐观预期。不过,投行摩根士丹利则警告称,HIMS近期涨幅过大,适当时机已错失,给予\"持平\"评级并大幅下调目标价。该投行预计HIMS今年一季度业绩或将逊于市场预期。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0}}}